Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442
Patient Information Leaflet last updated on the eMC: 03/12/2009
PIL Tegretol Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/12/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 11/09/2009 and displayed until 03/12/2009
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to date of revision
Updated on 09/03/2009 and displayed until 11/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 20/06/2008 and displayed until 09/03/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 05/06/2003 and displayed until 20/06/2008
Reasons for adding or updating:
  • Update to PIL
Updated on 13/11/2001 and displayed until 05/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 02/01/2001 and displayed until 13/11/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   carbamazepine


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk